Multiple sclerosis: reprogramming the immune repertoire with alemtuzumab in MS.

Wiendl, Heinz

Multiple sclerosis: reprogramming the immune repertoire with alemtuzumab in MS. [electronic resource] - Nature reviews. Neurology Mar 2013 - 125-6 p. digital

Publication Type: Journal Article

1759-4766

10.1038/nrneurol.2013.2 doi


Alemtuzumab
Antibodies, Monoclonal, Humanized--therapeutic use
Antigens, CD--immunology
Antigens, Neoplasm--immunology
CD52 Antigen
Clinical Trials, Phase III as Topic
Glycoproteins--immunology
Humans
Multiple Sclerosis--immunology